» Articles » PMID: 1586058

The Effect of Maternal Smoking During Pregnancy on Early Infant Lung Function

Overview
Specialty Pulmonary Medicine
Date 1992 May 1
PMID 1586058
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effect of prenatal maternal cigarette smoking on the pulmonary function (PF) of 80 healthy infants tested shortly after birth (mean, 4.2 +/- 1.9 wk). Mothers' prenatal smoking was measured by: (1) questionnaire reports at each prenatal visit of the number of cigarettes smoked per day, and (2) urine cotinine concentrations (corrected for creatinine) obtained at each visit. Infant PF was assessed by partial expiratory flow-volume curves and helium-dilution measurement of FRC. Forced expiratory flow rates were significantly lower in infants born to smoking mothers, both when unadjusted and after controlling for infant size, age, sex, and passive exposure to environmental tobacco smoke (ETS) between birth and the time of PF testing. Flow at functional residual capacity (VFRC) in infants born to smoking mothers was lower than that found in infants whose mothers did not smoke during pregnancy (74.3 +/- 15.9 versus 150.4 +/- 8.9 ml/s; p = 0.0007). Differences remained significant when flow was corrected for lung size (VFRC/FRC: 0.87 +/- 0.26 versus 1.77 +/- 0.12 s-1; p = 0.013). No differences in pulmonary function were evident among infants exposed and unexposed to ETS in the home after stratifying by prenatal exposure status. We conclude that maternal smoking during pregnancy is associated with significant reductions in forced expiratory flow rates in young infants. The results suggest that maternal smoking during pregnancy may impair in utero airway development and/or alter lung elastic properties. We speculate that these effects of maternal prenatal smoking on early levels of forced expiratory flow may be an important factor predisposing infants to the occurrence of wheezing illness later in childhood.

Citing Articles

The Role of Lung Function in Determining Which Children Develop Asthma.

McEvoy C, Le Souef P, Martinez F J Allergy Clin Immunol Pract. 2023; 11(3):677-683.

PMID: 36706985 PMC: 10329781. DOI: 10.1016/j.jaip.2023.01.014.


Protocol for iSISTAQUIT: Implementation phase of the supporting indigenous smokers to assist quitting project.

Gould Judean G, Kumar R, Ryan N, Stevenson L, Oldmeadow C, La Hera Fuentes G PLoS One. 2022; 17(11):e0274139.

PMID: 36350896 PMC: 9645649. DOI: 10.1371/journal.pone.0274139.


Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study.

Boueiz A, Xu Z, Chang Y, Masoomi A, Gregory A, Lutz S Chronic Obstr Pulm Dis. 2022; 9(3):349-365.

PMID: 35649102 PMC: 9448009. DOI: 10.15326/jcopdf.2021.0275.


A polygenic risk score and age of diagnosis of COPD.

Zhang J, Xu H, Qiao D, DeMeo D, Silverman E, OConnor G Eur Respir J. 2022; 60(3).

PMID: 35115341 PMC: 9969342. DOI: 10.1183/13993003.01954-2021.


Is Upregulated by Second-Hand Smoke Exposures and Is a Key Factor Contributing to Aggravated Lung Responses in Adult Emphysema, Asthma, and Lung Cancer Mouse Models.

Noel A, Perveen Z, Xiao R, Hammond H, Le Donne V, Legendre K Front Physiol. 2021; 12:704401.

PMID: 34912233 PMC: 8667558. DOI: 10.3389/fphys.2021.704401.